This article has been updated from an earlier version to include share price and details.

NEW YORK, Nov. 2 (GenomeWeb News) - Shares in Ciphergen Biosystems came to within 3 cents of their 52-week low in late-afternoon trade today after the company reported a 30-percent decline in third-quarter revenue and a nearly doubled net loss.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.